NYX Nyse Euronext

NYSE Euronext (NYX) today announced trading volumes for its global cash equities and derivatives exchanges for June 20091. Trading volumes in June 2009 generally receded from May 2009 levels, but ended the quarter with solid increases year-over-year across all venues, including increases of 24.9% in U.S. cash trading, 6.1% in European cash trading, 10.2% in European derivatives and 71.3% in U.S. equity options. European interest rate derivatives average daily volume (�ADV�) in June were at their highest levels since April 2008.

Highlights

• NYSE, NYSE Arca and NYSE Amex (�NYSE Group�) U.S. cash products handled ADV in June 2009 increased 0.6%, compared to June 2008. NYSE Group matched share of all U.S. equity trading volume in June 2009 was 29.7%, compared to market share of 20.8% for our next largest competitor.
• NYSE Euronext is the largest exchange operator in the two fastest growing tapes in the U.S. equity markets. Total Tape A consolidated ADV and Tape B consolidated ADV in June 2009 increased a combined 23.6%, compared to June 2008. Tape A and Tape B trading volume in June accounted for approximately 75% of all Consolidated Tape trading in the U.S. market which includes trade reporting facility (�TRF�) volumes.
• NYSE Euronext European cash products ADV of 1.3 million transactions in June 2009 decreased 9.4%, compared to June 2008. For the second quarter 2009, ADV of 1.5 million transactions was 6.1% above the second quarter 2008 and 5.8% above the first quarter 2009. European cash products ADV year-to-date of 1.4 million transactions was 6.6% below the same period last year.
• NYSE Euronext European derivatives products ADV in June 2009 was 4.6 million contracts, up 2.5% from June 2008 driven by a 15.5% increase in Bclear OTC volumes. Total interest rate products ADV was 2.4 million contracts, up 3.7% compared to June 2008 and at their highest levels since April 2008.
• NYSE Euronext U.S. equity options ADV of 2.8 million contracts in June 2009 represented an increase of 66.4%, compared to June 2008 levels. The increase in ADV was driven mostly by the addition of the former Amex options business and stronger options market volumes.

Cash Trading

U.S. Cash

NYSE Group U.S. cash products handled ADV in June 2009 increased 0.6% to 3.2 billion shares, compared to June 2008, but decreased 16.0% from May 2009. In the second quarter 2009, ADV of 3.6 billion was 24.9% above the second quarter 2008, but 9.5% below the first quarter 2009. Year-to-date, NYSE Group handled ADV of 3.8 billion shares was 19.4% above the same period last year. NYSE Group matched share of all U.S. equity volume in June 2009 was 29.7%, compared to 20.8% for our next largest competitor.

NYSE-listed (Tape A)

• Total Tape A consolidated ADV in June 2009 increased 12.8% to 5.3 billion shares compared to 4.7 billion shares in June 2008, but declined 18.5% compared to May 2009. In the second quarter 2009, Tape A consolidated ADV of 6.1 billion shares was 46.0% above the second quarter 2008. Year-to-date, total Tape A consolidated ADV of 6.2 billion shares was 42.8% above the prior year period.
• Tape A matched ADV of NYSE Group in June 2009 decreased 1.5% to 2.1 billion shares compared to June 2008. In the second quarter 2009, Tape A matched ADV of 2.4 billion shares was 22.8% above the second quarter 2008, but 9.5% below first quarter 2009 levels. Year-to-date, NYSE Group matched ADV in Tape A increased 16.6% compared to the prior year period.
• NYSE Group�s Tape A matched market share in June 2009 was 39.9% up from 38.9% in May 2009, compared to market share of 15.3% for our next largest competitor. TRF market share across Tape A increased in June 2009 to 32.3% from 25.0% in December 2008.
• Designated Market Maker (�DMM�) participation in June 2009 was 9.1%, compared to 10.1% in May 2009. Supplemental Liquidity Provider (�SLP�) participation in June 2009 was 7.5%, up from a revised 6.9% in May 2009. DMM and SLP participation pertain only to trading on NYSE.

NYSE Arca and NYSE Amex-listed (Tape B)

• Total Tape B consolidated ADV in June 2009 increased 65.7% to 2.0 billion shares compared to 1.2 billion shares in June 2008, but decreased 17.0% compared to May 2009. In the second quarter 2009, Tape B consolidated ADV of 2.3 billion shares was 128.1% above second quarter 2008, but 4.7% below the first quarter 2009. Year-to-date, total Tape B consolidated ADV of 2.3 billion shares was 114.0% above the prior year period.
• NYSE Group�s matched ADV of Tape B in June 2009 increased 48.2% to 479 million shares compared to June 2008, but declined 13.2% compared to May 2009. In the second quarter 2009, Tape B matched ADV of 531 million shares increased 95.3% compared to second quarter 2008, but decreased 11.9% from the first quarter of 2009. Year-to-date, NYSE Group Tape B matched ADV was 80.8% above the prior year period.
• Tape B matched market share of NYSE Group in June 2009 was 23.9%, compared to market share of 21.2% for our next largest competitor. TRF market share across Tape B increased in June 2009 to 36.4% from 21.5% in December 2008.

Nasdaq-listed (Tape C)

• Total Tape C consolidated ADV in June 2009 increased 9.3% to 2.5 billion shares, compared to 2.3 billion shares in June 2008. Tape C consolidated volumes represented approximately 25% of all Consolidated Tape trading in the U.S. in June 2009. In the second quarter 2009, Tape C consolidated ADV of 2.4 billion shares increased 14.8% compared to second quarter 2008. Year-to-date, total Tape C consolidated ADV was 2.4% above the prior year period.
• NYSE Group�s matched ADV of Tape C decreased 15.7% to 306 million shares in June 2009 compared to 363 million shares in June 2008. In the second quarter 2009, matched ADV in Tape C decreased 8.1% compared to second quarter 2008. Year-to-date, NYSE Group�s Tape C matched ADV decreased 10.6% to 336 million shares.
• NYSE Group�s Tape C matched market share was 12.4%, compared to 32.4% for our nearest competitor. TRF market share across Tape C increased in June 2009 to 39.9% from 29.9% in December 2008.

Exchange Traded Funds

• NYSE Group matched exchange-traded funds ADV (included in volumes from Tape B and Tape C noted above) increased 30.8% to 456 million shares in June 2009. In the second quarter 2009, matched exchange-traded funds ADV increased 80.5%, compared to the second quarter 2008, but decreased 14.3% compared to the first quarter of 2009. Year-to-date, matched exchange-traded funds ADV was 68.2% above the prior year period.

European Cash

NYSE Euronext European cash products ADV of 1.3 million transactions in June 2009 decreased 9.4%, compared to June 2008 and decreased 10.5% compared to May 2009. For the second quarter 2009, ADV of 1.5 million transactions was 6.1% above the second quarter 2008 and 5.8% above the first quarter 2009. European cash products ADV year-to-date of 1.4 million transactions was 6.6% below the same period last year. As previously announced, on April 1, 2009 NYSE Euronext introduced an integrated transaction fee structure across its pan-European cash equity markets which is based on a fee per executed order instead of a fee per trade. As expected, the net capture rate for European cash declined in-line with expectations when the new pricing structure was announced.

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in June 2009 was 4.6 million futures and options contracts, an increase of 2.5% from June 2008, but down 17.4% from the record 5.6 million contracts recorded in May 2009. The 4.6 million in futures and options contracts ADV in June 2009 consisted of 3.4 million contracts executed through our full-service CONNECT trading platform and a total of 1.2 million contracts executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. For the second quarter 2009, European derivatives products ADV was 4.9 million contracts, 10.2% above the 4.4 million contracts recorded in the second quarter 2008. Year-to-date European derivatives products ADV of 4.3 million contracts was 3.6% below prior year levels.

• Total interest rate products ADV increased 3.7% to 2.4 million contracts from 2.3 million contracts in June 2008 and increased 11.1% from May 2009. Total interest rate products ADV increased for the third consecutive month and is at its highest level since April 2008. For the second quarter 2009, interest rate products ADV of 2.2 million contracts is down 5.0% compared to the 2.3 million contracts in the second quarter 2008, but increased 8.8% from first quarter 2009. Year-to-date, total interest rate products ADV decreased 17.6% compared to the prior year period.
• Total equity products (including Bclear) ADV increased 1.4% to 2.2 million contracts from June 2008, but decreased 36.2% compared to May 2009. Total equity products ADV in June executed through our full-service CONNECT trading platform was 1.0 million contracts, in-line with June 2008 and May 2009. In the second quarter 2009, total equity products ADV of 2.7 million contracts was 26.7% above the second quarter 2008. Year-to-date total equity products ADV increased 15.0% above the prior year period.
• The 36.2% decrease in total equity products ADV compared to May 2009 was driven in large part by a 46.3% decrease in individual equity products, principally through Bclear. The decrease in individual equity products ADV through Bclear was driven by a drop off in single-stock futures trading in June.

U.S. Derivatives

NYSE Euronext�s U.S. equity options (NYSE Arca and NYSE Amex) ADV in June 2009 increased 66.4% to 2.8 million contracts compared to June 2008, and increased 8.9% compared to May 2009. June 2009 ADV reflected seasonally higher levels of institutional flow, driven in part by the benefit of new technology from the rollout of the new trading floor, that resulted in an increase in market share. This business is traditionally lower margin. Total U.S. consolidated options ADV increased 0.8% to 13.4 million contracts in June 2009, but decreased 9.2% from May 2009. Year-to-date, U.S. equity options volume of 2.4 million contracts was 41.4% above the prior year period. NYSE Euronext�s U.S. options exchanges accounted for 20.5% of the total consolidated equity options trading in June 2009, up from 12.4% in June 2008, and up from the 17.1% recorded in May 2009.

Other Metrics

The average EUR/USD exchange rate for the second quarter of 2009 of $1.36 represented an increase of 4.4% from the first quarter of 2009, but a decrease of 12.8% compared to the second quarter of 2008. Year-to-date, the average EUR/USD exchange rate is running 12.8% below the same period last year. The average GBP/USD exchange rate for the second quarter of 2009 of $1.55 represented an increase of 8.0% from the first quarter of 2009, but a decrease of 21.4% compared to the second quarter of 2008. Year-to-date, the average GBP/USD exchange rate is running 24.4% below the same period last year.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With more than 8,000 listed issues, NYSE Euronext's equities markets -- the New York Stock Exchange, Euronext, NYSE Arca and NYSE Amex -- represent nearly 40 percent of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, the leading European derivatives business and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the S&P 100 index and Fortune 500. For more information, please visit: www.nyx.com

Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext�s plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext�s current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext�s results to differ materially from current expectations include, but are not limited to: NYSE Euronext�s ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext�s reference document for 2008 ("document de r�f�rence") filed with the French Autorit� des March�s Financiers (Registered on April 28, 2009 under No. R. 09-031), 2008 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorit� des March�s Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

1 Euronext equities transactions count each buy and sell order as separate transactions, NYSE Group equities transactions count buy and sell orders together as a single transaction. All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. Prior year period does not include the former Amex equities and options businesses.

NYSE Euronext Monthly Volume Summary - Cash Products � � � � � � � � � � Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited) Jun-09 Jun-08 % Chg Jun-09 Jun-08 % Chg YTD 2009 % Chg vs. YTD 2008 YTD 2009 % Chg vs. YTD 2008 � Number of Trading Days - European Markets 22 21 22 21 125 125 Number of Trading Days - U.S. Markets 22 21 22 21 124

�

124 � European Cash Products (trades in thousands) 1,320 1,457 -9.4% 29,034 30,604 -5.1% 1,414 -6.6% 176,812 -7.3% � Equities 1,266 1,411 -10.2% 27,859 29,625 -6.0% 1,352 -7.5% 169,003 -8.2% Exchange-Traded Funds 13 7 97.6% 296 143 107.0% 14 85.3% 1,783 83.8% Structured Products 34 34 -1.0% 747 721 3.7% 43 6.5% 5,324 5.7% Bonds 6 5 8.9% 131 115 14.0% 6 0.8% 702 0.0% �

U.S. Cash Products (shares in millions) 2

3,220 3,200 0.6% 70,842 67,191 5.4% 3,831 19.4% 474,991 18.4% � NYSE Listed (Tape A) Issues 1 � NYSE Group Handled Volume 2 2,301 2,391 -3.8% 50,612 50,215 0.8% 2,777 16.0% 344,346 15.1% NYSE Group Matched Volume 3 2,110 2,142 -1.5% 46,427 44,984 3.2% 2,518 16.6% 312,247 15.6% Total NYSE Listed Consolidated Volume 5,287 4,688 12.8% 116,306 98,439 18.2% 6,228 42.8% 772,291 41.7% � NYSE Group Share of Total Consolidated Volume Handled Volume 2 43.5% 51.0% -7.5% 43.5% 51.0% -7.5% 44.6% -10.3% 44.6% -10.3% Matched Volume 3 39.9% 45.7% -5.8% 39.9% 45.7% -5.8% 40.4% -9.1% 40.4% -9.1% � NYSE Arca & Amex (Tape B) Listed Issues � NYSE Group Handled Volume 2 543 372 45.8% 11,942 7,819 52.7% 646 78.0% 80,042 76.5% NYSE Group Matched Volume 3 479 323 48.2% 10,532 6,784 55.2% 566 80.8% 70,246 79.3% Total NYSE Arca & Amex Listed Consolidated Volume 1,999 1,207 65.7% 43,988 25,347 73.5% 2,307 114.0% 286,062 112.3% � NYSE Group Share of Total Consolidated Volume Handled Volume 2 27.1% 30.8% -3.7% 27.1% 30.8% -3.7% 28.0% -5.7% 28.0% -5.7% Matched Volume 3 23.9% 26.8% -2.9% 23.9% 26.8% -2.9% 24.6% -4.5% 24.6% -4.5% � Nasdaq Listed (Tape C) Issues � NYSE Group Handled Volume 2 377 436 -13.6% 8,287 9,157 -9.5% 408 -9.8% 50,602 -10.5% NYSE Group Matched Volume 3 306 363 -15.7% 6,731 7,618 -11.6% 336 -10.6% 41,686 -11.4% Total Nasdaq Listed Consolidated Volume 2,461 2,252 9.3% 54,143 47,289 14.5% 2,323 2.4% 288,024 1.6% � NYSE Group Share of Total Consolidated Volume Handled Volume 2 15.3% 19.4% -4.1% 15.3% 19.4% -4.1% 17.6% -2.4% 17.6% -2.4% Matched Volume 3 12.4% 16.1% -3.7% 12.4% 16.1% -3.7% 14.5% -2.1% 14.5% -2.1% � Exchange-Traded Funds 1,4 � NYSE Group Handled Volume 2 516 399 29.4% 11,353 8,376 35.5% 644 66.6% 79,811 65.3% NYSE Group Matched Volume 3 456 349 30.8% 10,031 7,319 37.1% 566 68.2% 70,168 66.9% Total ETF Consolidated Volume 1,983 1,262 57.1% 43,618 26,495 64.6% 2,358 108.5% 292,412 106.8% � NYSE Group Share of Total Consolidated Volume Handled Volume 2 26.0% 31.6% -5.6% 26.0% 31.6% -5.6% 27.3% -6.9% 27.3% -6.9% Matched Volume 3 23.0% 27.6% -4.6% 23.0% 27.6% -4.6% 24.0% -5.7% 24.0% -5.7% NYSE Euronext Monthly Volume Summary - Derivatives Products � � � � � � � � � � Average Daily Volume Total Volume Average Daily Volume Total Volume (Unaudited; contracts in thousands) Jun-09 Jun-08 % Chg Jun-09 Jun-08 % Chg YTD 2009 % Chg vs. YTD 2008 YTD 2009 % Chg vs. YTD 2008 � Number of Trading Days - European Markets 22 21 22 21 125 125 Number of Trading Days - U.S. Markets 22 21 22 21 124 124 � European Derivatives Products 4,612 4,500 2.5% 101,455 94,495 7.4% 4,327 -3.6% 540,844 -4.4% of which Bclear 1,170 1,013 15.5% 25,744 21,270 21.0% 1,186 44.8% 148,239 43.7% � Total Interest Rate Products 2,412 2,325 3.7% 53,059 48,829 8.7% 2,074 -17.6% 259,247 -18.2% � Short Term Interest Rate Products 2,322 2,232 4.0% 51,073 46,875 9.0% 1,974 -18.0% 246,800 -18.7%

Medium and Long Term Interest Rate Products 5

90 93 -3.0% 1,985 1,954 1.6% 100 -7.1% 12,447 -7.9% � Total Credit Derivatives Products (Bclear) - - - - - - � Total Equity Products 6 2,150 2,121 1.4% 47,292 44,535 6.2% 2,206 15.0% 275,691 14.1% � Individual Equity Products 1,503 1,443 4.2% 33,066 30,298 9.1% 1,569 23.0% 196,159 22.0% Equity Index Products 647 678 -4.6% 14,226 14,236 -0.1% 636 -0.8% 79,532 -1.6% � of which Bclear 1,170 1,013 15.5% 25,744 21,270 21.0% 1,186 44.8% 148,239 43.7% Individual Equity Products 1,029 895 15.0% 22,632 18,789 20.5% 1,050 45.9% 131,234 44.8% Equity Index Products 141 118 19.7% 3,111 2,481 25.4% 136 36.5% 17,005 35.4% �

Commodity Products

50 54 -6.8% 1,104 1,131 -2.4% 47 -16.6% 5,905 -17.3% of which Bclear - - - - - - � U.S. Derivatives Products � U.S. Derivatives Products - Equity Options 7 � NYSE Group Options Contracts 2,758 1,658 66.4% 60,670 34,813 74.3% 2,438 41.4% 302,309 40.3% Total Consolidated Options Contracts 13,442 13,334 0.8% 295,714 280,016 5.6% 13,686 6.9% 1,697,023 6.0% � NYSE Group Share of Total 20.5% 12.4% 20.5% 12.4% 17.8% 4.3% 17.8% 4.3% � NYSE Liffe U.S. � Precious Metals Futures Volume 14.1 - 309.8 - 17.4 - 2,158.1 - � � 1Includes all volume executed in NYSE Group crossing sessions. 2Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and executed at an external market center. NYSE Arca routing includes odd-lots. 3Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges. 4Data included in previously identified categories. 5Data includes currency products.

6Includes all trading activities for Bclear, Euronext.liffe's clearing service for wholesale equity derivatives.

7Includes trading in U.S. equity options contracts, not equity-index options.

� Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities. All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells. US Equities data has been updated for Amex integration for October 2008 forward.